₹ 0.8 Cr
Volume Transacted
(Dec 27, 2024)
10.1 K
Stocks Traded
(Dec 27, 2024)
Last Updated on: Dec 28, 2024
Shilpa Medicare Ltd
NSE: SHILPAMED
Net Profit
₹ 17.94
Last updated on: Dec 28, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
27 Dec 2024 | 768.7 | 771.8 | 777.45 | 759.6 |
26 Dec 2024 | 764.75 | 801.15 | 801.15 | 760 |
24 Dec 2024 | 765.95 | 777.35 | 784.9 | 765.1 |
23 Dec 2024 | 778 | 808.1 | 819.85 | 765.65 |
20 Dec 2024 | 814.4 | 820.25 | 844 | 800.75 |
19 Dec 2024 | 829 | 815.05 | 836.3 | 815.05 |
18 Dec 2024 | 830.55 | 800.05 | 862.5 | 800.05 |
17 Dec 2024 | 822.45 | 794.55 | 826.05 | 794.55 |
16 Dec 2024 | 810.65 | 809.05 | 832.9 | 802 |
13 Dec 2024 | 816 | 815 | 827.8 | 796.5 |
Date | Price (₹) |
---|---|
27 Dec 2024 | 768.7 |
26 Dec 2024 | 764.75 |
24 Dec 2024 | 765.95 |
23 Dec 2024 | 778 |
20 Dec 2024 | 814.4 |
19 Dec 2024 | 829 |
18 Dec 2024 | 830.55 |
17 Dec 2024 | 822.45 |
16 Dec 2024 | 810.65 |
13 Dec 2024 | 816 |
Historical Revenue of Shilpa Medicare Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Shilpa Medicare Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Shilpa Medicare Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Shilpa Medicare's Unit IV and Unit VII secures Eurasia GMP approval
Shilpa Medicare, Unit IV, Jadcherla, Telangana, India and Shilpa Medicare, Unit VII, Nacha...
27 Dec 2024 11:36
Shilpa Medicare gets GMP approval for Hyderabad facilities
Both units of Shilpa Medicare's (Unit IV and Unit VII) have now received GMP approval of E...
27 Dec 2024 12:19
Shilpa Medicare gets GMP certification for Hyderabad Facility
The inspection was conducted from 24 September 2024 to 26 September 2024. On conclusion of...
20 Dec 2024 15:14
Shilpa Medicare JV gets USFDA approval for IMKELDI drug
Oncosol is 50:50 joint venture between Liqmeds Lifecare, a Zydus Group company, and Koana ...
27 Nov 2024 15:47
Shilpa Medicare gets nod for Phase III clinical trials of Human Albumin
Albumin is in high demand for various medical treatments, including restoring blood volume...
26 Nov 2024 15:00
Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine
Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...
19 Nov 2024 11:24
Unlimited trading starting at just Rs. 249*